Cited by 992Cancer Risks and FactorsBRCA gene mutations in cancerGlobal Cancer Incidence and Screening

Key steps for effective breast cancer prevention

Britt, Kara L., Cuzick, Jack, Phillips, Kelly-Anne·2020·Nature Reviews Cancer

Abstract

Despite decades of laboratory, epidemiological and clinical research, breast cancer incidence continues to rise. Breast cancer remains the leading cancer-related cause of disease burden for women, affecting one in 20 globally and as many as one in eight in high-income countries. Reducing breast cancer incidence will likely require both a population-based approach of reducing exposure to modifiable risk factors and a precision-prevention approach of identifying women at increased risk and targeting them for specific interventions, such as risk-reducing medication. We already have the capacity to estimate an individual woman's breast cancer risk using validated risk assessment models, and the accuracy of these models is likely to continue to improve over time, particularly with inclusion of newer risk factors, such as polygenic risk and mammographic density. Evidence-based risk-reducing medications are cheap, widely available and recommended by professional health bodies; however, widespread implementation of these has proven challenging. The barriers to uptake of, and adherence to, current medications will need to be considered as we deepen our understanding of breast cancer initiation and begin developing and testing novel preventives.

Integrity signals

Registry

Crossref · 10.1038/s41568-020-0266-x

Cites

263 of 263 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Zamani et al. considered mindfulness-based cognitive therapy effective on distress tolerance and cognitive distress in diabetic patients.

    “زواًی ٍ ّوىاضاى زضهاى قٌاذتی هثتٌی تط شّي آگاّی ضا تط تحول پطیكاًی ٍ اًقغاف پصیطی قٌاذتی تیواضاى هثتلا تِ زیاتت ًَؿ زٍ هؤحط زاًؿتِ اًس ( )52”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Britt, K. L., Cuzick, J., & Phillips, K.-A.
Affiliations
  • The University of Melbourne (AU)
  • Queen Mary University of London (GB)
Corresponding author
Britt, Kara L.
Venue
Nature Reviews Cancer
Published
2020-06-11
Volume
20
Issue
8
Pages
417-436
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
OpenAlex
W3035321842
Cited by
992
References
263
Citations by year
2026: 58 · 2025: 149 · 2024: 205 · 2023: 163 · 2022: 293 · 2021: 109 · 2020: 15
FWCI
15.60
Type
journal article
Language
en
Open access
closed
Locations
  • Nature reviews. Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
Funders
  • Barts Charity (MGU0461)
  • Cancer Research UK (16891)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords
breast cancer prevention, breast cancer incidence, modifiable risk factors, personalized prevention, polygenic risk, breast density, tamoxifen, raloxifene, medication adherence, barriers to uptake, breast cancer initiation, high-income countries
MeSH terms
Antineoplastic Agents, Breast Neoplasms, Female, Humans, Risk Factors, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review